期刊文献+

氯胺酮脑保护作用的可能机制 被引量:8

Protective mechanisms of ketamine on ischemia induced cerebral damage
原文传递
导出
摘要 众多研究显示,氯胺酮对脑缺血缺氧性损伤具有保护作用。主要通过调节神经细胞凋亡;与NMDA受体结合,抑制兴奋性氨基酸毒性及钙离子内流;抑制炎性因子生成和蛋白激酶表达等几个方面发挥脑保护作用。 Ketamine is a commonly used anesthetic agent, and is also the unique noncompetitive NMDA receptor antagonist used in clinic. Recently studies have shown that ketamine does not alter cerebral hemodynamics adversely when given to patients under mechanical ventilation and background anesthetics. More studies also shown ketamine has neuroprotective effects. The main mechanisms may involve in changing the expression of apoptosis-regulating proteins, inhibiting the toxicibility of excitatory amino acid, and decreasing Ca^2+ influx by blockade of NMDA receptors activation. Ketamine can also inhibit proinflammatory cytokine production induced by tissue ischemia and affect the protein kinase phosphorylations related to cerebral ischemia. There are also some other mechanisms. The aim of our review is to summarize the possible neuroprotective mechanisms of ketamine.
出处 《国际麻醉学与复苏杂志》 CAS 2007年第2期191-192,I0001,共3页 International Journal of Anesthesiology and Resuscitation
关键词 氯胺酮 脑缺血 脑保护 ketamine ischemia neuroprotective
  • 相关文献

参考文献4

二级参考文献23

  • 1杜冠华,张均田.丹酚酸A对小鼠脑缺血再灌注致学习记忆功能障碍的改善作用及作用机制[J].药学学报,1995,30(3):184-190. 被引量:84
  • 2Tassonyi E, Charpantier E, Muller D, Dumont L, Bertrand D.The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia[J]. Brain Res Bull, 2002;57:133 - 50
  • 3Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J]. Science, 2002; 298:1911-2
  • 4Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation[ J]. Oncogene, 2004; 23: 2838 - 49
  • 5Takagi Y, Nozaki K, Sugino T, Hattori I, Hashimoto N. Phosphorylation of c-Jun NH(2)-terminal kinase and p38 mitogenactivated protein kinase after transient forebrain ischemia in mice [J]. Neurosci Lett, 2000;294:117- 20
  • 6Piao CS, Kim JB, Han PL, Lee JK. Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult [J]. J Neurosci Res, 2003; 73: 537 - 44
  • 7MC, Rivera-Cervantes, J Segura Torres, A Feria-Velasco, J Armendariz-Borunda, C Beas-Zarate. NMDA and AMPA receptor expression and cortical neuronal death are associated with p38 in glutamate-induced excitotoxicity in vivo [ J]. J Neurosci Res,2004;76:678 - 87
  • 8Ozden S, Isenmann S. Neuroprotective properties of different anesthetics on axotomized rat retinal ganglion cells in vivo [ J]. J Neurotrauma, 2004; 21:73 - 82
  • 9Preston E, Webster J. Spectrophotometric measurement of experimental brain injury[J]. J Neurosci Methods, 2000;94:187-92
  • 10Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases [ J ].Nat Rev Drug Discov, 2003;2:717- 26

共引文献12

同被引文献60

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部